258 related articles for article (PubMed ID: 23438889)
1. Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.
Umićević Mirkov M; Coenen MJ
Pharmacogenomics; 2013 Mar; 14(4):425-44. PubMed ID: 23438889
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in rheumatoid arthritis.
Sen D; Paul JR; Ranganathan P
Methods Mol Biol; 2014; 1175():625-60. PubMed ID: 25150878
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics in rheumatoid arthritis.
Ranganathan P
Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of disease-modifying anti-rheumatic drugs.
Tanaka E; Taniguchi A; Urano W; Yamanaka H; Kamatani N
Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):233-47. PubMed ID: 15121042
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate pharmacogenetics in rheumatoid arthritis.
Brinker RR; Ranganathan P
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S33-9. PubMed ID: 21044431
[TBL] [Abstract][Full Text] [Related]
6. An update on methotrexate pharmacogenetics in rheumatoid arthritis.
Ranganathan P
Pharmacogenomics; 2008 Apr; 9(4):439-51. PubMed ID: 18384257
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of therapies in rheumatoid arthritis.
Ranganathan P
Drugs Today (Barc); 2005 Dec; 41(12):799-814. PubMed ID: 16474855
[TBL] [Abstract][Full Text] [Related]
8. Personalized medicine in rheumatoid arthritis: hopes and challenges.
Bridges SL
Bull NYU Hosp Jt Dis; 2007; 65(3):174-7. PubMed ID: 17922665
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics in treatment of rheumatoid arthritis.
Kooloos WM; Huizinga TW; Guchelaar HJ; Wessels JA
Curr Pharm Des; 2010; 16(2):164-75. PubMed ID: 20205662
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacogenomics of antirheumatic drugs and personalized medicine for rheumatoid arthritis].
Taniguchi A; Urano W; Tanaka E; Kamatani N
Nihon Rinsho; 2007 Feb; 65(2):371-9. PubMed ID: 17302286
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics and pharmacogenomics for rheumatoid arthritis responsiveness to methotrexate treatment: the 2013 update.
Zhu H; Deng FY; Mo XB; Qiu YH; Lei SF
Pharmacogenomics; 2014 Mar; 15(4):551-66. PubMed ID: 24624921
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis.
Aluko A; Ranganathan P
Methods Mol Biol; 2022; 2547():527-567. PubMed ID: 36068476
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacogenetics of disease modifying anti-rheumatic drugs].
Taniguchi A; Urano W; Tanaka E; Akama H; Yamanaka H; Kamatani N
Nihon Rinsho; 2002 Dec; 60(12):2339-44. PubMed ID: 12510359
[TBL] [Abstract][Full Text] [Related]
14. The role of anti-malarials in rheumatoid arthritis--the American experience.
Khraishi MM; Singh G
Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
[TBL] [Abstract][Full Text] [Related]
15. [Combination therapy of disease-modifying antirheumatic drugs(DMARDs) in rheumatoid arthritis].
Kobayashi S; Kanai Y
Nihon Rinsho; 2002 Dec; 60(12):2351-6. PubMed ID: 12510361
[TBL] [Abstract][Full Text] [Related]
16. Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to tnf alpha blocking agents? A review analysis of the literature.
Ingegnoli F; Favalli EG; Meroni PL
Autoimmun Rev; 2011 Jun; 10(8):460-3. PubMed ID: 21296193
[TBL] [Abstract][Full Text] [Related]
17. Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice.
Taniguchi A; Urano W; Tanaka E; Furihata S; Kamitsuji S; Inoue E; Yamanaka M; Yamanaka H; Kamatani N
Pharmacogenet Genomics; 2007 Jun; 17(6):383-90. PubMed ID: 17502830
[TBL] [Abstract][Full Text] [Related]
18. The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.
Tarnowski M; Paradowska-Gorycka A; Dąbrowska-Zamojcin E; Czerewaty M; Słuczanowska-Głąbowska S; Pawlik A
Expert Opin Drug Metab Toxicol; 2016; 12(1):41-55. PubMed ID: 26609565
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and Pharmacogenetics.
Conti V; Corbi G; Costantino M; De Bellis E; Manzo V; Sellitto C; Stefanelli B; Colucci F; Filippelli A
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33327600
[TBL] [Abstract][Full Text] [Related]
20. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Watson KD; Silman AJ; Symmons DP;
Rheumatology (Oxford); 2006 Dec; 45(12):1558-65. PubMed ID: 16705046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
